Symbol="CLSD"
AssetType="Common Stock"
Name="Clearside Biomedical Inc"
Description="Clearside Biomedical, Inc., a biopharmaceutical company, is dedicated to developing and delivering treatments that restore and preserve vision for people with serious eye diseases. The company is headquartered in Alpharetta, Georgia."
CIK="1539029"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="73999000"
EBITDA="-30122000"
PERatio="None"
PEGRatio="0"
BookValue="0.044"
DividendPerShare="0"
DividendYield="0"
EPS="-0.61"
RevenuePerShareTTM="0.016"
ProfitMargin="0"
OperatingMarginTTM="-30.73"
ReturnOnAssetsTTM="-0.468"
ReturnOnEquityTTM="-2.01"
RevenueTTM="984000"
GrossProfitTTM="1123000"
DilutedEPSTTM="-0.61"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.988"
AnalystTargetPrice="5.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.639"
PriceToBookRatio="3.927"
EVToRevenue="0.744"
EVToEBITDA="-4.828"
Beta="2.103"
num_52WeekHigh="1.855"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.152"
num_200DayMovingAverage="1.207"
SharesOutstanding="61666000"
DividendDate="None"
ExDividendDate="None"
symbol="CLSD"
open="1.16"
high="1.23"
low="1.15"
price="1.20"
volume="141992.00"
latest_trading_day="2023-07-14"
previous_close="1.18"
change="0.02"
change_percent="1.6949%"
aroon_positive_momentum_days="63"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="162919"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.66"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="1114"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0147.jpeg"
image_negative_thumbnail_id_2="164"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0012.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="620"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
